Second Heart Team
Howard Leonhardt
Chairman of the Board
Jeff Donofrio
President, Board Director
Dr. Leslie Miller
Chief Medical Officer, Board Director
Alex Richardson
Chief Technology Officer, Vice President Engineering and Product Development, Board Director
Stuart Kozlick
Chief Strategy Officer
Dr. Mark Cunningham
Board Director, Chief Advisor Cardio-Thoracic Surgery (Independent)
Dr. Dinesh Patel
Board Director, Chief Advisor Business Development, Audit Committee Chair (Independent)
Dr. Patrick Griffith
Board Director, Senior Advisor CardioThoracic Surgery, MBA Healthcare Business Advisor (Independent)
Mark Libratore
Board Director (Independent)
Larry Stevens
Chief FDA Regulatory Affairs Consultant
Todd Seiger
Chief Reimbursement Consultant
Dr. Samer Banihani
Chief Nephrologist Kidney Health Advisor
Robyn Thornburgh
Board Advisor
Anthony Domenici
Contract Chief Financial Advisor, Accounts Payable Team Leader
Sejal Chaudhari
Research Coordinator, Pre-Clinical Studies Director, Regulatory Affairs
Kapil Sharma
Investor Relations, Regulatory Affairs Bioengineer
Ben Boytor
Chief Advisor Quality Management Systems
Dr. William Abraham
Chairman Scientific Advisory Board, Heart Failure Expert Consultant
Brian Hardy
Director of Marketing, Website Development
Allen Turner
Chief Patent Counsel Trask Britt
Bruce Methven
Chief Legal Counsel MethvenLaw
Sheryl Melancon
Assistant to the President
Natalie Tinnirello
Executive Assistant
Lisa Weinburg
Senior Regulatory Consultant
Peter McBride
Senior Business Development Advisor
Kurt Kruger
Senior Financial Analyst
Dr. Tim Henry
Senior Interventional Cardiology Advisor
Dr. Nicolas Chronos
Senior Interventional Cardiology Advisor
Dr. Barry Greenberg
Senior Heart Failure Advisor
Dr. Mahinda Vilathgamuwa
Senior Engineering Advisor
Dr. Zvonmir Krajcer
Senior Interventional Cardiology Advisor
Note – All team members and board directors hold other positions within the industry.
Warning:
Investigational Use Only: Not Available for Sale. Product not yet tested to support any clinical claims. Early stage development.
WARNING: Early stage development. NOT AVAILABLE FOR SALE. INVESTIGATIONAL USE ONLY WITH PROPER REGULATORY CLEARANCES ONLY. Animal use only at this time. Prospective, randomized, multi-center, double blinded, placebo controlled clinical evaluations of Second Heart circulatory assist pumps to assess safety in supporting cardiovascular haemodynamics in patients have yet to be completed. No clinical claims for these devices are supported at this time.